A detailed history of Everpar Advisors LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Everpar Advisors LLC holds 3,511 shares of NVO stock, worth $306,756. This represents 0.22% of its overall portfolio holdings.

Number of Shares
3,511
Previous 4,541 22.68%
Holding current value
$306,756
Previous $648 Million 35.5%
% of portfolio
0.22%
Previous 0.32%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

SELL
$119.07 - $145.42 $122,642 - $149,782
-1,030 Reduced 22.68%
3,511 $418 Million
Q2 2024

Jul 18, 2024

BUY
$122.71 - $146.91 $81,970 - $98,135
668 Added 17.25%
4,541 $648 Million
Q1 2024

Apr 22, 2024

SELL
$102.11 - $135.92 $230,155 - $306,363
-2,254 Reduced 36.79%
3,873 $497 Million
Q4 2023

Feb 06, 2024

BUY
$87.78 - $105.45 $537,828 - $646,092
6,127 New
6,127 $634 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Everpar Advisors LLC Portfolio

Follow Everpar Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Everpar Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Everpar Advisors LLC with notifications on news.